Found: 11
Select item for more details and to access through your institution.
Effect of FAK inhibitor VS‐6063 (defactinib) on docetaxel efficacy in prostate cancer.
- Published in:
- Prostate, 2018, v. 78, n. 4, p. 308, doi. 10.1002/pros.23476
- By:
- Publication type:
- Article
Analogous detection of circulating tumor cells using the AccuCyte<sup>®</sup>—CyteFinder<sup>®</sup> system and ISET system in patients with locally advanced and metastatic prostate cancer.
- Published in:
- Prostate, 2018, v. 78, n. 4, p. 300, doi. 10.1002/pros.23474
- By:
- Publication type:
- Article
Prostatectomy‐based validation of combined urine and plasma test for predicting high grade prostate cancer.
- Published in:
- Prostate, 2018, v. 78, n. 4, p. 294, doi. 10.1002/pros.23473
- By:
- Publication type:
- Article
Histological and quantitative analyzes of the stromal and acinar components of normal human prostate zones.
- Published in:
- Prostate, 2018, v. 78, n. 4, p. 289, doi. 10.1002/pros.23472
- By:
- Publication type:
- Article
Capillarisin blocks prostate‐specific antigen expression on activation of androgen receptor in prostate carcinoma cells.
- Published in:
- Prostate, 2018, v. 78, n. 4, p. 242, doi. 10.1002/pros.23463
- By:
- Publication type:
- Article
Comparing sequencing of abiraterone and enzalutamide in men with metastatic castration‐resistant prostate cancer: A retrospective study.
- Published in:
- Prostate, 2018, v. 78, n. 4, p. 278, doi. 10.1002/pros.23470
- By:
- Publication type:
- Article
Validation of histone deacetylase 3 as a therapeutic target in castration‐resistant prostate cancer.
- Published in:
- Prostate, 2018, v. 78, n. 4, p. 266, doi. 10.1002/pros.23467
- By:
- Publication type:
- Article
Prostate tumors downregulate microseminoprotein‐beta (MSMB) in the surrounding benign prostate epithelium and this response is associated with tumor aggressiveness.
- Published in:
- Prostate, 2018, v. 78, n. 4, p. 257, doi. 10.1002/pros.23466
- By:
- Publication type:
- Article
Correlations of SELENOF and SELENOP genotypes with serum selenium levels and prostate cancer.
- Published in:
- Prostate, 2018, v. 78, n. 4, p. 279, doi. 10.1002/pros.23471
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Prostate, 2018, v. 78, n. 4, p. 241, doi. 10.1002/pros.23411
- Publication type:
- Article
Systemic immune‐inflammation index predicts the combined clinical outcome after sequential therapy with abiraterone and docetaxel for metastatic castration‐resistant prostate cancer patients.
- Published in:
- Prostate, 2018, v. 78, n. 4, p. 250, doi. 10.1002/pros.23465
- By:
- Publication type:
- Article